Familial isolated hypoparathyroidism due to impaired PTH secretion

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:189466OMIM:146200E20.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial isolated hypoparathyroidism due to impaired PTH secretion is a rare inherited endocrine disorder characterized by low or absent parathyroid hormone (PTH) secretion in the absence of other associated developmental or autoimmune abnormalities. Unlike syndromic forms of hypoparathyroidism (such as DiGeorge syndrome or autoimmune polyendocrinopathy), this condition affects the parathyroid glands in isolation, resulting in deficient PTH production or release despite structurally present parathyroid tissue. PTH is essential for maintaining calcium and phosphorus balance in the body, and its deficiency leads to hypocalcemia (low blood calcium) and hyperphosphatemia (high blood phosphorus). The condition primarily affects the endocrine and neuromuscular systems. Key clinical features include muscle cramps, tingling and numbness in the hands, feet, and around the mouth (paresthesias), muscle spasms (tetany), and in severe cases, seizures due to critically low calcium levels. Chronic hypocalcemia can also lead to calcification of the basal ganglia in the brain, cataracts, dental abnormalities, and cardiac rhythm disturbances. Symptoms may present in infancy, childhood, or later in life depending on the specific genetic cause and severity of the PTH secretion defect. Several genetic causes have been identified, including mutations in the PTH gene itself, the GCM2 (GCMB) gene which is a transcription factor critical for parathyroid gland development and function, and gain-of-function mutations in the calcium-sensing receptor (CASR) gene that cause the parathyroid glands to inappropriately suppress PTH secretion at normal or low calcium levels. Treatment consists of lifelong supplementation with oral calcium and active vitamin D analogs (such as calcitriol or alfacalcidol) to maintain serum calcium levels within an acceptable range. Recombinant PTH (such as teriparatide or PTH 1-84) may be considered in refractory cases. Regular monitoring of serum calcium, phosphorus, renal function, and urinary calcium excretion is essential to prevent complications such as nephrocalcinosis and kidney stones.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Familial isolated hypoparathyroidism due to impaired PTH secretion.

View clinical trials →

No actively recruiting trials found for Familial isolated hypoparathyroidism due to impaired PTH secretion at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial isolated hypoparathyroidism due to impaired PTH secretion community →

No specialists are currently listed for Familial isolated hypoparathyroidism due to impaired PTH secretion.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial isolated hypoparathyroidism due to impaired PTH secretion.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial isolated hypoparathyroidism due to impaired PTH secretionForum →

No community posts yet. Be the first to share your experience with Familial isolated hypoparathyroidism due to impaired PTH secretion.

Start the conversation →

Latest news about Familial isolated hypoparathyroidism due to impaired PTH secretion

No recent news articles for Familial isolated hypoparathyroidism due to impaired PTH secretion.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial isolated hypoparathyroidism due to impaired PTH secretion

What is Familial isolated hypoparathyroidism due to impaired PTH secretion?

Familial isolated hypoparathyroidism due to impaired PTH secretion is a rare inherited endocrine disorder characterized by low or absent parathyroid hormone (PTH) secretion in the absence of other associated developmental or autoimmune abnormalities. Unlike syndromic forms of hypoparathyroidism (such as DiGeorge syndrome or autoimmune polyendocrinopathy), this condition affects the parathyroid glands in isolation, resulting in deficient PTH production or release despite structurally present parathyroid tissue. PTH is essential for maintaining calcium and phosphorus balance in the body, and its